Danish biotech industry has become more mature and a number of companies have come so far in their development that 11 companies are planning to go public within the next three years. Of these, six companies have scheduled their quotations in 2009. Sunstone Capital has carried out a survey in which general managers and board members in Medicon Valley anonymously were asked about their plans.
